section name header

Indications

High Alert


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Availability

Route/Dosage

US Brand Names

Hyftor

Action

  • Inhibits mammalian target of rapamycin activation. Mechanism in treatment of angiofibroma associated with tuberous sclerosis unknown.
Therapeutic effects:
  • Reduction in size and redness of facial angiofibroma.

Classifications

Therapeutic Classification: Immunosuppressant agents

Pharmacokinetics

Absorption: Minimally absorbed into systemic circulation.

Distribution: Not distributed to tissues.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
Topicalunknownunknownunknown

Patient/Family Teaching

Pronunciation

sir-OH-li-mus

Code

NDC Code